| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/12/2006 | WO2006107254A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 10/12/2006 | WO2006107253A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 10/12/2006 | WO2006107252A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 10/12/2006 | WO2006107184A1 A pharmaceutical composition for the treatment of atopic dermatitis containing 4-hydroxy-5-methoxy-4-[2-methyl-3-(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro [2,5]octan-6-one |
| 10/12/2006 | WO2006107107A1 Myocardial protective agent comprising phospholipid liposome and method for prevention of myocardial disorder occurring under ischemia/reperfusion |
| 10/12/2006 | WO2006107097A1 Nasal vaccine |
| 10/12/2006 | WO2006107062A2 Benzimidazole derivative and use as angiotensin ii antagonist |
| 10/12/2006 | WO2006107059A1 Medicine for renal perfusion disorder |
| 10/12/2006 | WO2006107027A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia |
| 10/12/2006 | WO2006107019A1 Preventive or remedy for depression or anxiety neurosis |
| 10/12/2006 | WO2006106995A1 Matrix metalloproteinase inhibitor comprising ingredient extracted from amula |
| 10/12/2006 | WO2006106986A1 Agent for alleviating vascular insufficiency |
| 10/12/2006 | WO2006106984A1 Potentiator for radiation therapy comprising pyridine derivative as active ingredient |
| 10/12/2006 | WO2006106983A1 Radiotherapy enhancer |
| 10/12/2006 | WO2006106963A1 Triamine derivative |
| 10/12/2006 | WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 10/12/2006 | WO2006106915A1 PROTECTIVE AGENT FOR RETINAL NEURONAL CELL CONTAINING PROSTAGLANDIN F2α DERIVATIVE AS ACTIVE INGREDIENT |
| 10/12/2006 | WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group |
| 10/12/2006 | WO2006106889A1 Methods of producing sodium alginate-containing tablet and tablets obtained by the production methods |
| 10/12/2006 | WO2006106888A1 Oral composition for promoting defecation containing patchouli oil and dietary fiber |
| 10/12/2006 | WO2006106887A1 Edible composition containing component extracted from salix sp. extract |
| 10/12/2006 | WO2006106839A1 METHOD FOR SCREENING AUXILIARY AGENT CAPABLE OF PROMOTING THE INDUCTION OF INTERFERON-α AND/OR -β (IFN-α/β) EXPRESSION |
| 10/12/2006 | WO2006106812A1 Propane-1,3-dion derivative or salt thereof |
| 10/12/2006 | WO2006106805A1 Method of improving the storage stability of substance |
| 10/12/2006 | WO2006106804A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 10/12/2006 | WO2006106778A1 Bcrp/abcg2 inhibitor |
| 10/12/2006 | WO2006106727A1 Benzyloxypropylamine derivative |
| 10/12/2006 | WO2006106721A1 Pyrimidine derivative having tyrosine kinase inhibitory effect |
| 10/12/2006 | WO2006106711A1 Antifungal agent containing pyridine derivative |
| 10/12/2006 | WO2006106529A1 A co-spray dried composition of cefepime with base and process for preparation thereof |
| 10/12/2006 | WO2006106521A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 10/12/2006 | WO2006106520A2 Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes |
| 10/12/2006 | WO2006106519A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 10/12/2006 | WO2006106437A2 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 10/12/2006 | WO2006106427A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 10/12/2006 | WO2006106426A1 An oxindole oxazolidinone as antibacterial agent |
| 10/12/2006 | WO2006106425A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 10/12/2006 | WO2006106416A1 PYRIDIL-LACTAMS AND THEIR USE 5 -HTl RECEPTORS LIGAN |
| 10/12/2006 | WO2006106372A1 New crystalline atorvastatin hemicalcium salt polymorph form |
| 10/12/2006 | WO2006106358A2 Use of nk-3 receptor antagonists for the treatment of nausea and vomiting |
| 10/12/2006 | WO2006106350A1 Anti-inflammatory formulation |
| 10/12/2006 | WO2006106344A2 Abuse resistant capsules |
| 10/12/2006 | WO2006106326A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 10/12/2006 | WO2006106308A1 Therapeutic use of nefopam and analogues thereof |
| 10/12/2006 | WO2006106307A1 Pyrimidine derivatives for use as anticancer agents |
| 10/12/2006 | WO2006106306A1 Pyrimidines as igf-i inhibitors |
| 10/12/2006 | WO2006106241A1 Piperazine derivatives and use thereof as serotonin reuptake inhibitors or as neurokinin antagonists |
| 10/12/2006 | WO2006106220A2 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
| 10/12/2006 | WO2006106169A1 Phosphorothioates derived from nucleoside analogues for antiretroviral therapy |
| 10/12/2006 | WO2006106135A1 Crystal form of asenapine maleate |
| 10/12/2006 | WO2006106103A2 Prevention of hiv- infection with tmc278 |
| 10/12/2006 | WO2006106090A1 Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 10/12/2006 | WO2006106054A1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 10/12/2006 | WO2006106052A1 Pyrazoles |
| 10/12/2006 | WO2006106046A1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors |
| 10/12/2006 | WO2006105979A1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 10/12/2006 | WO2006105971A1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs |
| 10/12/2006 | WO2006105945A1 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and their use in the production of medicaments |
| 10/12/2006 | WO2006105865A1 Indazole squaric acid derivatives as chk1-, chk2- and sgk- inhibitors |
| 10/12/2006 | WO2006105850A1 Acyl hydrazides as kinase inhibitors, in particular for sgk |
| 10/12/2006 | WO2006105844A1 Pyrazole derivatives |
| 10/12/2006 | WO2006105811A1 Compounds useful as modulators of the proteasome activity |
| 10/12/2006 | WO2006105806A1 Delaying the ageing process and disorders caused by ageing |
| 10/12/2006 | WO2006105800A1 Nac ( n-acetylin cysteine ) in the treatment of unexplained rpl (recurrent pregnancy loss) |
| 10/12/2006 | WO2006105798A2 Benzimidazole formulation |
| 10/12/2006 | WO2006105796A1 Novel indolinone derivatives |
| 10/12/2006 | WO2006105795A1 Novel indolinone derivatives |
| 10/12/2006 | WO2006105728A1 Diarylheptanoids, preparation and the use thereof |
| 10/12/2006 | WO2006105726A1 A composition for treating hypertension |
| 10/12/2006 | WO2006105725A1 A combination of luteolin and one of pt chemotherapeutics |
| 10/12/2006 | WO2006105708A1 A medicine composition for treating cardiac and cerebral vascular disease |
| 10/12/2006 | WO2006105697A1 Piperidyl-2, 6-dione derivatives used to inhibit cells from releasing tumor necrosis factor |
| 10/12/2006 | WO2006105670A1 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain |
| 10/12/2006 | WO2006105666A1 Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis |
| 10/12/2006 | WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response |
| 10/12/2006 | WO2006105643A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 10/12/2006 | WO2006090129A3 Bicalutamide for delivering increasing steady state plasma levels |
| 10/12/2006 | WO2006087147A3 Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia |
| 10/12/2006 | WO2006082412A3 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 10/12/2006 | WO2006081088A8 Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid |
| 10/12/2006 | WO2006078283A3 Quinoxaline inhibitors of hedgehog signalling |
| 10/12/2006 | WO2006074045A3 Immune response modifier formulations and methods |
| 10/12/2006 | WO2006073786A3 Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
| 10/12/2006 | WO2006073430A9 Therapeutic delivery system comprising a high molecular weight peg-like compound |
| 10/12/2006 | WO2006072589A3 Disubstituted ureas as kinase inhibitors |
| 10/12/2006 | WO2006066956A3 Sulfonamido-macrocycles as tie2 inhibitors |
| 10/12/2006 | WO2006066914A3 Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
| 10/12/2006 | WO2006066879A3 Compounds with kv4 ion channel activity |
| 10/12/2006 | WO2006064351A3 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 10/12/2006 | WO2006063281A3 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 10/12/2006 | WO2006059304A3 Novel lactame derivatives as renin inhibitors |
| 10/12/2006 | WO2006059221A3 Topical hydro-alcoholic formulations of oxazolidinone antibacterial agents |
| 10/12/2006 | WO2006050926A3 Extended surface aggregates in the treatment of skin conditions |
| 10/12/2006 | WO2006050520A3 Antipyretic compositions and methods |
| 10/12/2006 | WO2006050239A3 Muscarinic acetylcholine receptor antagonists |
| 10/12/2006 | WO2006048750A3 Novel compounds of substituted and unsubstituted adamantyl amides |
| 10/12/2006 | WO2006048336A3 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 10/12/2006 | WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 10/12/2006 | WO2006047032A3 Indole compounds useful as serotonin selective agents |
| 10/12/2006 | WO2006046854A3 Flavour modulating substances |